We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+3.95%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$4.07B
AUM Growth
+$112M
Cap. Flow
+$150M
Cap. Flow %
3.69%
Top 10 Hldgs %
67.28%
Holding
50
New
14
Increased
13
Reduced
13
Closed
5
Avg Time Held Equity + Options
10 quarters
Top 10 Avg Time Held Equity + Options
9.9 quarters
Top 20 Avg Time Held Equity + Options
7.8 quarters
Avg Time Held Equity only
10.2 quarters
Top 10 Avg Time Held Equity only
10 quarters
Top 20 Avg Time Held Equity only
8.2 quarters

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$113M
2
PYPL icon
PayPal
PYPL
+$94.8M
3
AMZN icon
Amazon
AMZN
+$88.9M
4
THC icon
Tenet Healthcare
THC
+$73.4M
5
DIS icon
Walt Disney
DIS
+$39.5M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$77.8M
2
UBER icon
Uber
UBER
+$68.5M
3
CLVT icon
Clarivate
CLVT
+$60.1M
4
TFX icon
Teleflex
TFX
+$58.7M
5
DNB icon
Dun & Bradstreet
DNB
+$51.4M

Sector Composition

Rank Sector Weight
1 Healthcare 51.34%
2 Industrials 13.8%
3 Technology 13.59%
4 Consumer Discretionary 7.77%
5 Financials 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CVS icon
1
CVS Health
CVS
$114B
$809M 19.9%
11,946,799
– –
2023 Q4
5 quarters
THC icon
2
Tenet Healthcare
THC
$21.8B
$457M 11.23%
3,394,834
+557,749
+20% +$73.4M
2013 Q2
47 quarters
GPN icon
3
Global Payments
GPN
$21.2B
$371M 9.13%
3,793,683
-132,469
-3% -$13.9M
2020 Q4
17 quarters
TEVA icon
4
Teva Pharmaceutical Industries Limited
TEVA
$48.6B
$227M 5.58%
14,778,641
+6,322,317
+75% +$113M
2023 Q4
5 quarters
ALIT icon
5
Alight
ALIT
$242M
$194M 4.77%
1,635,484
+39,932
+3% +$5.25M
2022 Q3
10 quarters
UHS icon
6
Universal Health Services
UHS
$10.7B
$167M 4.1%
887,370
+8,072
+0.9% +$1.47M
2022 Q4
9 quarters
AMZN icon
7
Amazon
AMZN
$2.77T
$141M 3.48%
742,962
+409,637
+123% +$88.9M
2023 Q1
8 quarters
GTM icon
8
ZoomInfo Technologies
GTM
$1.14B
$128M 3.14%
12,786,800
+2,800,000
+28% +$29.4M
2024 Q2
3 quarters
CI icon
9
Cigna
CI
$75.2B
$123M 3.03%
374,057
-258,351
-41% -$77.8M
2013 Q2
47 quarters
DXC icon
10
DXC Technology
DXC
$2.01B
$119M 2.92%
6,959,119
-928,972
-12% -$18M
2017 Q2
31 quarters
USFD icon
11
US Foods
USFD
$20.9B
$117M 2.87%
1,785,729
+177,204
+11% +$12.1M
2021 Q4
13 quarters
EXPE icon
12
Expedia Group
EXPE
$32.6B
$109M 2.68%
647,961
-230,619
-26% -$42M
2022 Q3
10 quarters
CTVA icon
13
Corteva
CTVA
$8.95B
$87.6M 2.15%
1,392,104
-663,503
-32% -$41M
2019 Q4
21 quarters
DNB icon
14
DELISTED
Dun & Bradstreet
DNB
$87.3M 2.15%
9,768,483
-5,024,151
-34% -$51.4M
2022 Q3
10 quarters
CAR icon
15
Avis
CAR
$3.73B
$83.7M 2.06%
1,102,904
+452,307
+70% +$36.4M
2024 Q1
4 quarters
PYPL icon
16
PayPal
PYPL
$47.5B
$79.4M 1.95%
+1,216,652
New +$94.8M
2025 Q1
0 quarters
CNC icon
17
Centene
CNC
$34.2B
$79M 1.94%
1,301,660
+14,319
+1% +$865K
2024 Q4
1 quarter
VTRS icon
18
Viatris
VTRS
$20.2B
$74M 1.82%
8,492,943
-830,376
-9% -$8.72M
2023 Q4
5 quarters
KNX icon
19
Knight Transportation
KNX
$10.1B
$61.1M 1.5%
1,404,054
+200,000
+17% +$10.3M
2023 Q1
8 quarters
ESI icon
20
Element Solutions
ESI
$8.93B
$57.2M 1.41%
2,531,937
+81,356
+3% +$2.08M
2016 Q3
34 quarters
MCK icon
21
McKesson
MCK
$114B
$55.1M 1.35%
81,852
-69,766
-46% -$43.1M
2016 Q4
33 quarters
BC icon
22
Brunswick
BC
$3.99B
$39.4M 0.97%
731,638
+295,630
+68% +$18.5M
2023 Q3
6 quarters
DIS icon
23
Walt Disney
DIS
$187B
$36.3M 0.89%
+367,712
New +$39.5M
2025 Q1
0 quarters
MYGN icon
24
Myriad Genetics
MYGN
$396M
$34.6M 0.85%
3,899,550
-257,774
-6% -$3.1M
2019 Q3
22 quarters
PINS icon
25
Pinterest
PINS
$12.3B
$33M 0.81%
1,063,523
+705,167
+197% +$23.9M
2024 Q4
1 quarter
1
2

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Glenview Capital Management held 50 positions worth $4.07B, up 2.8% from $3.96B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Glenview Capital Management deployed $150M of net new capital in Q1 2025, opening 14 new positions and adding to 13 existing holdings. Its largest new stake was PayPal: 1,216,652 shares worth $79.4M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 47% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Cigna, an estimated $77.8M trimmed.

  • Glenview Capital Management's largest Q1 2025 buy was PayPal: 1,216,652 shares worth $79.4M.
  • Glenview Capital Management added most to Teva Pharmaceutical Industries Limited in Q1 2025, an estimated $113M increase.
  • Glenview Capital Management's biggest Q1 2025 reduction was Cigna, cutting an estimated $77.8M.
  • Glenview Capital Management fully exited Teleflex in Q1 2025, selling an estimated $58.7M.
  • Glenview Capital Management's ten largest holdings make up 67% of its $4.07B portfolio in Q1 2025.
  • Glenview Capital Management opened 14 new positions and closed 5 in Q1 2025.
  • Glenview Capital Management's portfolio value rose 2.8% quarter-over-quarter to $4.07B.

Based on Glenview Capital Management's 13F filing for Q1 2025, filed 15 May 2025.